SCD14 in bronchoalveolar lavage 18, 42 and 162 hours after segmental allergen provocation

Scandinavian Journal of Immunology

Volumn 71, Issue 4, 2010, Pages 304-311

  Julius, P ^a   Grosse Thie, C ^a   Kuepper, M ^a   Bratke, K ^a   Virchow, J C ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; LEUKOTRIENE D4; LIPOPOLYSACCHARIDE; MONTELUKAST; SOLUBLE CD4 ANTIGEN;

ADULT; ALLERGIC ASTHMA; ALLERGY TEST; ARTICLE; CELL COUNT; CELL FUNCTION; CELL KINETICS; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE CULTURE; LUNG LAVAGE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TIME;

ACETATES; ADOLESCENT; ADULT; ALLERGENS; ANTIGENS, CD14; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE D4; LIPOPOLYSACCHARIDES; MALE; QUINOLINES; TIME; YOUNG ADULT;

EID: 77949920520     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02375.x     Document Type: Article

References (51)

1. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999 354 : SII12 5.
2. Braun-Fahrländer C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002 347 : 869 877.
3. Lapa e Silva JR, Possebon da Silva MD, Lefort J, Vargaftig BB. Endotoxins, asthma, and allergic immune responses. Toxicology 2000 152 : 31 5.
4. Martinez FD. CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc 2007 4 : 221 225.
5. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps a region encoding growth factors and receptors. Science 1988 239 : 497 500.
6. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993 14 : 121 125.
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990 249 : 1431 1433.
8. Pålsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004 113 : 153 162.
9. Vasl J, Prohinar P, Gioannini TL, Weiss JP, Jerala R. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain. J Immunol 2008 180 : 6107 6115.
10. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003 74 : 479 485.
11. Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes in and alveolar macrophages. J Immunol 1993 150 : 2885 2891.
12. Gosset P, Tsicopoulos A, Wallaert B et al. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991 88 : 561 571.
13. Tillie-Leblond I, Pugin J, Marquette CH et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999 159 : 487 494.
14. Mattoli S, Marini M, Fasoli A. Expression of the potent inflammatory cytokines, GM-CSF, IL6, and IL8, in bronchial epithelial cells of asthmatic patients. Chest 1992 101 : 27S 9S.
15. Landmann R, Fisscher AK, Obrecht JP. Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages. J Leukoc Biol 1992 52 : 323 330.
16. Bufler P, Stiegler G, Schumacher M et al. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 1995 25 : 604 610.
17. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Govert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phophatidylinositol linkage. J Immunol 1988 141 : 547 552.
18. Landmann R, Calandra T, Zimmerli W. Soluble CD14 in septic shock. Prog Clin Biol Res 1995 392 : 375 380.
19. Krüger C, Schütt C, Obertacke U et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991 85 : 297 301.
20. Wüthrich B, Kägi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992 284 : 339 342.
21. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 1992 143 : 71 8.
22. Alexis N, Eldridge M, Reed W, Bromberg P, Peden DB. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol 2001 107 : 31 5.
23. Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995 151 : 544 547.
24. Hoheisel G, Zheng L, Teschler H, Striz I, Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995 108 : 1614 1616.
25. Martin TR, Rubenfeld G, Steinberg KP et al. Endotoxin, endotoxin-binding protein and soluble CD14 are present in bronchoalveolar fluid in patients with adult respiratory distress syndrome. Chest 1994 105 : 55S 6S.
26. Pforte A, Schiessler A, Gais P et al. Increased expression of the monocyte differentiation antigen CD14 in extrinsic allergic alveolitis. Monaldi Arch Chest Dis 1993 48 : 607 612.
27. Pforte A, Schiessler A, Gais P et al. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis. Chest 1994 105 : 349 354.
28. Dubin W, Martin TR, Swoveland P et al. Asthma and endotoxin: Lipopolysaccharide binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol 1996 270 : L736 44.
29. Virchow JC Jr., Julius P, Matthys H, Kroegel C, Luttmann W. CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. Eur Respir J 1998 11 : 317 323.
30. Garty BZ, Monselise Y, Nitzan M. Soluble CD14 in children with status asthmaticus. Isr Med Assoc J 2000 2 : 104 107.
31. George CL, White ML, O'Neill ME, Thorne PS, Schwartz DA, Snyder JM. Altered surfactant protein a gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 2003 285 : L1337 44.
32. Rylander R, Michel O. Organic dust induced inflammation-role of atopy and TLR-4 and CD14 gene polymorphisms. Am J Ind Med 2005 48 : 302 307.
33. Kitchens RL, Thompson PA, Viriyakosol S, O'Keefe GE, Munford RS. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. J Clin Invest 2001 108 : 485 493.
34. Bossé Y, Thompson C, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. Clin Exp Allergy 2008 38 : 113 121.
35. 4. Am J Respir Cell Mol Biol 2000 23 : 572 577.
36. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002 26 : 748 753.
37. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999 162 : 494 502.
38. Laan M, Cui ZH, Hoshino H et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999 162 : 2347 2352.
39. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003 170 : 2106 2112.
40. Laan M, Palmberg L, Larrson K, Linden A. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002 19 : 534 537.
41. Matthys H, Zeiss AW, Theissen JL, Virchow JC Jr., Werner P. Definition, normal reference and measurement values to diagnose obstructive, restrictive and mixed ventilatory defects for clinical lung function evaluation. Atemw-Lungenkrankh 1995 21 : 130 138.
42. Julius P, Lommatzsch M, Kuepper M et al. Safety of segmental allergen challenge in human allergic asthma. J Allergy Clin Immunol 2008 121 : 712 717.
43. Warren HS, Glennon ML, Wainwright N et al. Binding and neutralization of endotoxin by Limulus antilipopolysaccaride factor. Infect Immun 1992 60 : 2506 2513.
44. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 1996 64 : 1762 1769.
45. LeVan TD, Michel O, Dentener M et al. Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation. J Allergy Clin Immunol 2008 121 : 434 440.
46. Kabesch M, Hasemann K, Schickinger V et al. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 2004 59 : 520 525.
47. Zambelli-Weiner A, Ehrlich E, Stockton ML et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol 2005 115 : 1203 1209.
48. Lundell AC, Adlerberth I, Lindberg E et al. Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus. Clin Exp Allergy 2007 37 : 62 71.
49. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004 172 : 4470 4479.
50. Jovanovic DV, Di Battista JA, Martel-Pelletier J et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-ß and TNF-α, by human macrophages. J Immunol 1998 160 : 3513 3521.
51. Ichiyama T, Hasegawa S, Umeda M, Terai K, Matsubara T, Furukawa S. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells. Clin Exp Allergy 2003 33 : 802 807.